Notice of Intent to Sole Source – BioRender

The purpose of this acquisition is to provide the Clinical Center HEFS Department with RS Means Construction and Renovation Packages for estimation of costs. BioRender is an online scientific illustration software that offers simple drag-and-drop functionality. • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 513210 – Software Publishers • Place of Performance:

Bethesda, MD 20892 USA POTS:

24-011141 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order BioRender, located at 49 Spadina Ave Suite 200, Toronto, ON, M5V 2J1 Canada, on a firm fixed price sole source award basis to provide BioRender licenses. Below is a description of the item(s):

Description: Full access to BioRender for 12-month period Catalog #:

N/A Units: Each Quantity: 75 The proposed vendor, BioRender, is the sole authorized developer, distributor and support provider of the BioRender software worldwide.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.

Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by September 11, 2024 at 4pm EST.